Showing results (2051-2060 of 2,097) with videos related to
Sort By:
Pageof 210
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2025
A preclinical pig model of Angelman syndrome mirrors the early developmental trajectory of the human conditionLuke S Myers, Sarah G Christian, Sean Simpson, et al.Head & Neck|September 28, 2012
Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, VirginiaDavid J Adelstein, John A Ridge, David M Brizel, et al.Molecular Cancer Therapeutics|March 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination PartnersAatman S Doshi, Susan Cantin, Marylens Hernandez, et al.JAMA|October 6, 2005
Somatic acquisition and signaling of TGFBR1*6A in cancerBoris Pasche, Thomas J Knobloch, Yansong Bian, et al.Surgery|December 27, 2017
Relationship of procedural numbers with meaningful procedural autonomy in general surgery residentsHerbert P Stride, Brian C George, Reed G Williams, et al.Journal of Surgical Education|November 26, 2016
The Feasibility of Real-Time Intraoperative Performance Assessment With SIMPL (System for Improving and Measuring Procedural Learning): Early Experience From a Multi-institutional TrialJordan D Bohnen, Brian C George, Reed G Williams, et al.Pattern Recognition|November 1, 2021
Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoderShuo Liu, Jing Han, Estela Laporta Puyal, et al.The Journal of Allergy and Clinical Immunology|September 16, 2015
Practice parameter for the diagnosis and management of primary immunodeficiencyFrancisco A Bonilla, David A Khan, Zuhair K Ballas, et al.Communications Biology|January 26, 2021
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapyClaire M Patterson, Srividya B Balachander, Iain Grant, et al.Plos One|October 8, 2014
MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosisRobert N Booher, Harold Hatch, Brian M Dolinski, et al.Pageof 210